$CVRX
CVRx, Inc.

2022 Q1 Form 10-Q Financial Statement

#000155837022006644 Filed on May 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $4.076M $2.860M
YoY Change 42.52% 66.47%
Cost Of Revenue $949.0K $867.0K
YoY Change 9.46% 100.69%
Gross Profit $3.127M $1.993M
YoY Change 56.9% 54.98%
Gross Profit Margin 76.72% 69.69%
Selling, General & Admin $10.78M $4.460M
YoY Change 141.64% 94.42%
% of Gross Profit 344.64% 223.78%
Research & Development $2.258M $1.750M
YoY Change 29.03% -22.87%
% of Gross Profit 72.21% 87.81%
Depreciation & Amortization $62.00K $33.00K
YoY Change 87.88% 94.12%
% of Gross Profit 1.98% 1.66%
Operating Expenses $13.04M $6.210M
YoY Change 109.9% 36.09%
Operating Profit -$9.908M -$4.217M
YoY Change 134.95% 28.68%
Interest Expense $0.00 $601.0K
YoY Change -100.0% -197.41%
% of Operating Profit
Other Income/Expense, Net -$57.00K -$3.792M
YoY Change -98.5% -3746.15%
Pretax Income -$9.965M -$8.610M
YoY Change 15.74% 127.18%
Income Tax $26.00K $17.00K
% Of Pretax Income
Net Earnings -$9.991M -$8.627M
YoY Change 15.81% 126.25%
Net Earnings / Revenue -245.12% -301.64%
Basic Earnings Per Share -$0.49 -$23.92
Diluted Earnings Per Share -$0.49 -$23.92
COMMON SHARES
Basic Shares Outstanding 20.45M 360.7K
Diluted Shares Outstanding 20.45M 360.7K

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $131.2M $53.97M
YoY Change 143.05%
Cash & Equivalents $131.2M $53.97M
Short-Term Investments
Other Short-Term Assets $2.090M $1.059M
YoY Change 97.36%
Inventory $5.261M $3.029M
Prepaid Expenses
Receivables $3.673M $1.712M
Other Receivables $0.00 $0.00
Total Short-Term Assets $142.2M $59.77M
YoY Change 137.91%
LONG-TERM ASSETS
Property, Plant & Equipment $1.656M $478.0K
YoY Change 246.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $26.00K
YoY Change 0.0%
Total Long-Term Assets $2.204M $504.0K
YoY Change 337.3%
TOTAL ASSETS
Total Short-Term Assets $142.2M $59.77M
Total Long-Term Assets $2.204M $504.0K
Total Assets $144.4M $60.28M
YoY Change 139.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.607M $847.0K
YoY Change 89.73%
Accrued Expenses $4.985M $3.480M
YoY Change 43.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.592M $11.93M
YoY Change -44.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $19.35M
YoY Change -100.0%
Other Long-Term Liabilities $706.0K $825.0K
YoY Change -14.42%
Total Long-Term Liabilities $706.0K $20.17M
YoY Change -96.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.592M $11.93M
Total Long-Term Liabilities $706.0K $20.17M
Total Liabilities $7.602M $32.10M
YoY Change -76.32%
SHAREHOLDERS EQUITY
Retained Earnings -$404.7M
YoY Change
Common Stock $541.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $136.8M -$301.8M
YoY Change
Total Liabilities & Shareholders Equity $144.4M $60.28M
YoY Change 139.58%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$9.991M -$8.627M
YoY Change 15.81% 126.25%
Depreciation, Depletion And Amortization $62.00K $33.00K
YoY Change 87.88% 94.12%
Cash From Operating Activities -$10.64M -$5.038M
YoY Change 111.27% 10.7%
INVESTING ACTIVITIES
Capital Expenditures $293.0K $101.0K
YoY Change 190.1% -306.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$293.0K -$101.0K
YoY Change 190.1% 106.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 48.00K 2.000K
YoY Change 2300.0%
NET CHANGE
Cash From Operating Activities -10.64M -5.038M
Cash From Investing Activities -293.0K -101.0K
Cash From Financing Activities 48.00K 2.000K
Net Change In Cash -10.90M -5.141M
YoY Change 111.92% 11.76%
FREE CASH FLOW
Cash From Operating Activities -$10.64M -$5.038M
Capital Expenditures $293.0K $101.0K
Free Cash Flow -$10.94M -$5.139M
YoY Change 112.82% 14.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131177000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.92
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.92
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
360675
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
360675
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40545
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001235912
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20486971
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20399337
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.025
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
CY2022Q1 dei City Area Code
CityAreaCode
763
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
416-2840
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock,
CY2022Q1 dei Trading Symbol
TradingSymbol
CVRX
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20500177
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142072000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3673000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2560000
CY2022Q1 us-gaap Inventory Net
InventoryNet
5261000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2090000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2585000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
142201000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
151097000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1656000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
522000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2022Q1 us-gaap Assets
Assets
144405000
CY2021Q4 us-gaap Assets
Assets
152548000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1607000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4985000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6592000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5908000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
304000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
706000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
681000
CY2022Q1 us-gaap Liabilities
Liabilities
7602000
CY2021Q4 us-gaap Liabilities
Liabilities
6589000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20486971
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20399337
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
205000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
204000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
541547000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
540707000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-404745000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394754000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-204000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
136803000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144405000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152548000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4076000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
793000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
68000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2860000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
949000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
867000
CY2022Q1 us-gaap Gross Profit
GrossProfit
3127000
CY2021Q1 us-gaap Gross Profit
GrossProfit
1993000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2258000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1750000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10777000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4460000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
13035000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6210000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9908000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4217000
CY2021Q1 us-gaap Interest Expense
InterestExpense
601000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3792000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9965000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8610000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9991000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8627000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9997000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8631000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-23.92
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20453341
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360675
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9991000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
136803000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-293238000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8627000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-301806000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9991000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8627000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
793000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
61000
CY2022Q1 us-gaap Depreciation
Depreciation
62000
CY2021Q1 us-gaap Depreciation
Depreciation
33000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
431000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3689000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1113000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131177000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53971000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1381000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-314000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-485000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
454000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1097000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
364000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-596000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-55000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
500000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10644000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5038000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
293000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
101000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-293000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10895000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5141000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59112000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2399000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1593000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
753000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
482000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2109000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1805000
CY2022Q1 us-gaap Inventory Net
InventoryNet
5261000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3586000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3293000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1930000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1868000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1656000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q1 us-gaap Depreciation
Depreciation
62000
CY2021Q1 us-gaap Depreciation
Depreciation
33000
CY2022Q1 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1803000
CY2021Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1607000
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1202000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2028000
CY2022Q1 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
863000
CY2021Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
699000
CY2022Q1 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
216000
CY2021Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
380000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
208000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
162000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
531000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
684000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4985000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
522000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
208000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
304000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
512000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
171000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
234000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
139000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
544000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
32000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
512000
CY2022Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y3M18D
CY2022Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2022Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
39.548
CY2021Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11929584
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2749441
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.93
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
632988
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.85
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9100000
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87634
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.54
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3836
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.55
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
793000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3290959
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.29
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4238000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1167639
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.24
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3441000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.77
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.563
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.568
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0175
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0240
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9991000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8627000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20453341
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360675
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-23.92
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4007090
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14055431
CY2022Q1 us-gaap Contractual Obligation
ContractualObligation
0
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
0
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4076000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2860000

Files In Submission

Name View Source Status
0001558370-22-006644-index-headers.html Edgar Link pending
0001558370-22-006644-index.html Edgar Link pending
0001558370-22-006644.txt Edgar Link pending
0001558370-22-006644-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220331.xsd Edgar Link pending
tmb-20220331x10q.htm Edgar Link pending
tmb-20220331x10q_htm.xml Edgar Link completed
tmb-20220331xex31d1.htm Edgar Link pending
tmb-20220331xex31d2.htm Edgar Link pending
tmb-20220331xex32d1.htm Edgar Link pending
tmb-20220331xex32d2.htm Edgar Link pending
tmb-20220331_cal.xml Edgar Link unprocessable
tmb-20220331_def.xml Edgar Link unprocessable
tmb-20220331_lab.xml Edgar Link unprocessable
tmb-20220331_pre.xml Edgar Link unprocessable